5 enzyme kinetics-inhibition.ppt

5 enzyme kinetics-inhibitio

1. Enzyme Kinetics -Inhibition

2. Types of Inhibition
•Competitive Inhibition
•Noncompetitive Inhibition
•Uncompetitive Inhibition
•Irreversible Inhibition

3. .
S
I
Enzyme Competitive Inhibition
In competitive inhibition,
the inhibitor competes
with the substrate for the
same binding site

4. Competitive Inhibition
-Reaction Mechanism
In competitive inhibition, the
inhibitor binds only to the
free enzyme, not to the ES
complexE + SESE + P
EI
+
I

5. General Michaelis-Menten Equation
This form of the Michaelis-Menten equation
can be used to understand how each type of
inhibitor affects the reaction rate curvev =
[S]
K
m,app + [S]
V
max,app

6. In competitive inhibition, only the apparent K
m
is affected (K
m,app> K
m),
The V
maxremains unchanged by the presence
of the inhibitor.

7. Competitive inhibitors alter the
apparent K
m, not the V
max.
V
max
V
max
2
K
mK
m,app
[Substrate]
Reaction Rate
- Inhibitor
+ Inhibitor
V
max,app= V
max
K
m,app> K
m

8. The Lineweaver-Burk plot is
diagnostic for competitive inhibitionSlope =
Km,app
Vmax
1
Vmax
-1
Km,app
1
[S]
Increasing [I]
1
v
v
=
1
V
max
K
m,app
V
max
1
+
[S]
1

9. .
V
max
V
max
2
K
mK
m,app
[Substrate]
Reaction Rate
- Inhibitor
+ Inhibitor Inhibitor
competes with
substrate,
decreasing its
apparent affinity:
K
m,app> K
m
Formation of EI
complex shifts reaction
to the left: K
m,app> K
m
K
m,app> K
m
V
max,app= V
max
Formation of EI
complex shifts reaction
to the left: K
m,app> K
m
Relating the Michaelis-Menten equation, the v vs. [S]
plot, and the physical picture of competitive inhibition

10. Example -Competitive Inhibition
Sulfanilamide is a competitive
inhibitor of p-aminobenzoic
acid. Sulfanilamides (also
known as sulfa drugs,
discovered in the 1930s)
were the first effective
systemic antibacterial
agents.
Because we do not make folic
acid, sulfanilamides do not
affect human cells.COOH
NH
2
p-aminobenzoic acid
folic acid
SO
2NH
2
NH
2
sulfanilamide

11. Practical case: Methanol poisoning
A wealthy visitor is taken to
the emergency room, where
he is diagnosed with
methanol poisoning. You
are contacted by a 3rd year
medical student and asked
what to do? How would you
suggest treating this
patient?

12. Methanol (CH
3OH) is metabolized to
formaldehyde and formic acid by alcohol
dehydrogenase. You advisethe third year
student to get the patient very drunk.
Since ethanol (CH
3CH
2OH) competes with
methanol for the same binding site on
alcohol dehydrogenase, it slows the
metabolism of methanol, allowing the toxic
metabolites to be disposed of before they
build up to dangerous levels. By the way,
the patient was very grateful and decided
to leave all their worldly possessions to the
hospital. Unfortunately, after being
released from the hospital, he went to the
casinos and lost everything he had.

13. .
S
I
I
S
S
I
I
S
Enzyme
Enzyme
Enzyme
Enzyme Noncompetitive Inhibition
the inhibitor
does not
interfere with
substrate
binding (and
vice versa)

14. E + SESE + P
EI
+
I
ESI
+
I
S+ Noncompetitive Inhibition -
Reaction Mechanism
In noncompetitive
inhibition, the
inhibitor binds
enzyme
irregardless of
whether the
substrate is bound

15. Noncompetitive inhibitors decrease
the V
max,app, but don’t affect the K
m
V
max,app< V
max
K
m,app = K
m

16. The inhibitor binds
equally well to free
enzyme and the ES
complex, so it doesn’t
alter apparent affinity
of the enzyme for the
substrate
Why does K
m,app= K
mfor
noncompetitive inhibition?E + SESE + P
EI
+
I
ESI
+
I
S+

17. The Lineweaver-Burk plot is diagnostic
for noncompetitive inhibitionv
=
1
V
max,app
K
m
V
max,app
1
+
[S]
1
Slope =
Vmax,app
Km
1
Vmax,app
-1
Km
1
[S]
Increasing [I]
1
v

18. Formation of EI
complex shifts reaction
to the left: K
m,app> K
m
K
m,app> K
m
V
max,app= V
max.
S
I
I
S
S
I
I
S
Enzyme
Enzyme
Enzyme
Enzyme .
V
max
V
max2
1
2
1
V
max,app
K
mK
m,app
[Substrate]
Reaction Rate
- Inhibitor
+ Inhibitor
V
max,app
Inhibitor doesn’t interfere
with substrate binding,
K
m,app= K
m
Even at high
substrate levels,
inhibitor still binds,
[E]
t< [ES]
V
max,app< V
max
V
max,app< V
max
K
m,app= K
m
Relating the Michaelis-Menten equation, the v vs. [S] plot,
and the physical picture of noncompetitive inhibition

19. Noncompetitive inhibitors
decrease the apparent V
max, but
do not alter the K
mof the
reaction

20. Example of noncompetitive inhibition:
fructose 1,6-bisphosphatase inhibition by AMP

21. Fructose 1,6-bisphosphatase is a key regulatory
enzyme in the gluconeogenesis pathway. High
amounts of AMP signal that ATP levels are low and
gluconeogenesis should be shut down while
glycolysis is turned on.
High AMP levels inhibit fructose 1,6-bisphosphatase
(shutting down gluconeogenesis) and activate
phosphofructokinase (turning on glycolysis).
Regulation of fructose 1,6-bisphosphatase and
phosphofructokinase by AMP prevents a futile cycle
in which glucose is simultaneously synthesized and
broken down.

22. Uncompetitive Inhibition
In uncompetitive
inhibition, the
inhibitor binds
only to the ES
complex.
S
I
S
Enzyme Enzyme
I
Enzyme
S
Enzyme
I

23. Uncompetitive Inhibition -
Reaction Mechanism
In uncompetitive
inhibition, the
inhibitor binds only
to the ES complex,
it does not bind to
the free enzymeE + SESE + P
ESI
+
I

24. Uncompetitive inhibitors decrease
both the V
max,appand the K
m,app
V
max,app< V
max
K
m,app< K
m
Notice that at low substrate
concentrations,
uncompetitive inhibitors
have little effect on the
reaction rate because the
lower K
m,appof the enzyme
offsets the decreased V
max,app

25. Uncompetitive inhibitors decrease both the
V
max,appand the K
m,app of the enzymeE + SESE + P
ESI
+
I
Notice that
uncompetitive inhibitors
don’t bind to the free
enzyme, so there is no
EI complex in the
reaction mechanism

26. The Lineweaver-Burk plot is
diagnostic for uncompetitive inhibitionv
=
1
V
max,app
K
m,app
V
max,app
1
+
[S]
1
=
V
max
K
m
V
max,app
1
+
[S]
1
1
Vmax,app
-1
Km,app
1
[S]
Increasing [I]1
v
Slope =
Vmax
Km

27. .
V
max
V
max2
1
2
1
V
max,app
K
m
K
m,app
[Substrate]
Reaction Rate
- Inhibitor
+ Inhibitor
V
max,app Formation of EI
complex shifts reaction
to the left: K
m,app> K
m.
S
I
S
Enzyme Enzyme
I
Enzyme
S
Enzyme
I
Even at high
substrate levels,
inhibitor binds,
[E]
t< [ES]
V
max,app< V
max
Inhibitor
increases
the amount of
enzyme bound
to substrate
K
m,app< K
m
V
max,app< V
max
K
m,app< K
m
Relating the Michaelis-Menten equation, the v vs. [S]
plot, and the physical picture of uncompetitive inhibition

28. Uncompetitive inhibitors
decrease the apparent K
mof the
enzyme and decrease the V
maxof
the reaction

29. Example of uncompetitive inhibition: alkaline
phosphatase inhibition by phenylalanine.
Alkaline
phosphatase
OP
O
-
O
-
O
Alkaline
phosphatase
Phe
Alakaline
Phosphatase
Phe
Phe
O
P
O
-
O
-O
OP
O
-
O
-
O
P
O
-
O
-
O
-
O
Alkaline
phosphatase

30. At alkaline pH, alkaline phosphatase catalyzes
the release of inorganic phosphate from
phosphate esters. It is found in a number of
tissues, including liver, bile ducts, intestine,
bone, kidney, placenta, and leukocytes.
Alkaline phosphatase plays a role in the
deposition of hydroxyapetite in osteoid cells
during bone formation. The function of
alkaline phosphatase in other tissues is not
known. Serum alkaline phosphatase levels are
important diagnostic markers for bone and
liver disease.

31. Irreversible Inhibition
In irreversible
inhibition, the
inhibitor binds to the
enzyme irreversibly
through formation of
a covalent bond with
the enzyme ,
permanently
inactivating the
enzyme.
Enzyme
S
OI

32. Irreversible Inhibition -Reaction
Mechanism
In irreversible inhibition,
the inhibitor permanently
inactivates the enzyme.
The net effect is to remove
enzyme from the reaction.
V
maxdecreases
No effect on K
mE + SESE + P
EI
+
I

33. The Michaelis-Menten plot for an irreversible
inhibitor looks like noncompetitive inhibition
V
max,app< V
max
K
m,app= K
m.
V
max
V
max2
1
2
1
V
max,app
K
m
K
m,app
[Substrate]
Reaction Rate
- Inhibitor
+ Inhibitor
V
max,app

34. Irreversible inhibition is distinguished from
noncompetitive inhibition by plotting V
maxvs [E]
t
Enzyme is
inactivated
until all of the
irreversible
inhibitor is
used up

35. Irreversible inhibitors decrease
V
max,app, but leave the apparent
K
munchanged. Irreversible
inhibitors differ from other types
of inhibitors because they
covalently modify the enzyme.
This results in the permanent
inhibition of the enzyme activity.

36. Examples of Irreversible Inhibitors
•diisopropylphosphofluoridate
–prototype for the nerve gas sarin
–permanently inactivates serine proteases by
forming a covalent bond with the active site
serine

37. Penicillin is a suicide inhibitor
Glycopeptide transpeptidase catalyzes the formation of cross-links between D-
amino acids in the cell walls of bacteria. This enzyme also catalyzes the
reverse reaction, the hydrolysis of peptide bonds. During the course of
hydrolyzing the strained peptide bond in penicillin, the enzyme activates the
inhibitor (penicillin), which then covalently modifies an active site serine in
the enzyme. In effect, the enzyme “commits suicide” by hydrolyzing the
strained peptide bond in penicillin.glycopeptide
transpeptidase
OH
Ser
O
glycopeptide
transpeptidase
Ser
N
S
CH
3
CH
3
COO
-
H
H
C
C
O
H
N
C
O
H
H
R
N
S
CH
3
COO
-
H
H
C
C
O
H
N
C
O
H
Strained
peptide bond
Penicillin
CH
3
R

38. Suicide inhibitors work by
“tricking” the enzyme into
activating the inhibitor, which
then forms a covalent bond with
the enzyme, leading to its
permanent inactivation.

39. Summary-Enzyme Inhibition
•Competitive Inhibitor
–Binds to substrate binding site
–Competes with substrate
–The affinity of the substrate appears to be decreased
when inhibitor is present (K
m,app>K
m)
•Noncompetitive inhibitor
–Binds to allosteric site
–Does not compete with the substrate for binding to
the enzyme
–The maximum velocity appears to be decreased in
the presence of the inhibitor (V
max,app<V
max)

40. •Uncompetitive Inhibitor
–Binds to the enzyme only afterthe substrate has
bound
–The affinity of the substrate appears to be increased
and the maximum velocity appears to be decreased
when inhibitor is present (K
m,app<K
m,
V
max,app<V
max),
•Irreversible Inhibitor
–Covalently modifies and permanently inactivates the
enzyme